Bonjesta- the first dual release combination of doxylamine-pyridoxine for morning sickness

Motherisk Intl J 2020;1;19 Bonjesta- the first dual release combination of doxylamine-pyridoxine for morning sickness Gideon Koren, Rana Cohen, Adelson School of Medicine, Ariel University and Motherisk Israel Program   Question: The delayed release of doxylamine/ pyridoxine (Diclegis®) works well in many of my patients with morning sickness. The problem I have is that it…

Read More

THE CONTROVERSY OVER THE SAFETY OF ONDANSETRON IN PREGNANCY- WHY DOES IT CONTINUE?

Motherisk Int J 2020;1:10   Gideon Koren MD(1-2), Yusuf Cem Kaplan MD(3) Adelson Faculty of Medicine, Ariel University(1), Motherisk Israel Program (2) and Terafar – Izmir Katip Celebi University Teratology Information Center, Turkey (3)   Address for Correspondence: Adelson Faculty of Medicine, Ariel University, Ariel Israel 40700 gidiup_2000@yahoo.com   Acknowledgement: GK serves as a paid…

Read More

Hyperemesis Gravidarum- A Previously Unrecognized Human Teratogen

Motherisk Int J 2020;1:3 Asher Ornoy  and Matitiyahu Berkovitch MD Hebrew University and Tel Aviv University   Abstract: Question: Does hyperemesis gravidarum pause (HG) neurodevelopmental risk to the fetus? Answer: Recent studies have suggested that in HG the baby is at an increased risk for developmental delay and neurobehavioral risks, such as ADHD. These are…

Read More

Cannabis for Hyperemesis Gravidarum; A Risk: Benefit Balance

Motherisk Int J 2020;1:7 Rana Cohen BSc Pharm, Mati Berkovitch MD Motherisk Israel Program and Ariel University Faculty of Medicine   Abstract Question I see increasing reports in the social media of American women with hyperemesis gravidarum reporting on beneficial effects of cannabis in hyperemesis. What about the fetal risks of cannabis? Answer: Excellent question.…

Read More